Biomerica Inc (BMRA) stock
BMRANasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends May 31
Financials through Q1 FY2027, quarter ended Aug 31, 2026Last filing: 10-Q on Oct 15, 2026Score 8/3049% below fair value
$1.09−0.15 (-11.74%)
Close on Nov 18, 2026Market cap $5.01MP/E –Yield –
Biomerica pe ratio
The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.
Biomerica's pe ratio was 124.8× on Dec 31, 2013, against 7.8× a year earlier. Over the last 3 years it ranged from 7.4× to 150.4×, with a median of 11.0×.
PE Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2013 | Dec 31, 2013 | 124.8× | +117.0 |
| 2012 | Dec 31, 2012 | 7.8× | −3.2 |
| 2011 | Dec 30, 2011 | 11.0× | – |
See a number that looks wrong?